{"id":"W2581368499","doi":"10.1016/j.tcm.2017.01.009","title":"The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors","year":2017,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; University Health Network; University of Toronto; Women's College Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Alogliptin; Medicine; Empagliflozin; Semaglutide; Saxagliptin; Sitagliptin; Heart failure; Lixisenatide; Type 2 diabetes; Dulaglutide; Liraglutide; Internal medicine; Dapagliflozin; Dipeptidyl peptidase-4; Population; Pharmacology; Diabetes mellitus; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.01798786,0.001253055,0.01570018,0.00128689,0.0003536085,0.00006505643,0.0006361595,0.0006644761,0.00006019505],"category_scores_gemma":[0.001919183,0.0007007038,0.01014241,0.0008904163,0.00117821,0.0001143122,0.000464685,0.0008767099,0.00001420256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000447047,"about_ca_system_score_gemma":0.0002577296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000413869,"about_ca_topic_score_gemma":0.00003429771,"domain_scores_codex":[0.990559,0.001683287,0.003442641,0.001312853,0.002148182,0.0008540156],"domain_scores_gemma":[0.9926192,0.0008953004,0.00128235,0.004664666,0.0001729343,0.0003655509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006112688,0.00008223757,0.00004254541,0.009300684,0.0372722,0.0003830755,0.00009621456,0.000002512208,1.960871e-7,0.0001127747,0.005510835,0.9471356],"study_design_scores_gemma":[0.005697266,0.0003536821,0.0002539888,0.02496994,0.05520949,0.000129322,0.00007681154,0.000001681456,0.000003857139,0.00002442191,0.9127949,0.0004846577],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007518783,0.9824222,0.00001650541,0.0003960585,0.001881888,0.002455767,0.00006444956,0.00007357513,0.01268206],"genre_scores_gemma":[0.0002178832,0.9934512,0.00008344492,0.00002482928,0.002433948,0.0003887612,0.0006747555,0.0001636025,0.002561601],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9466509,"threshold_uncertainty_score":0.9997708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1154507040491829,"score_gpt":0.3786707929696252,"score_spread":0.2632200889204423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}